<VariationArchive RecordType="classified" VariationID="636274" VariationName="NM_031448.6(C19orf12):c.232_233del (p.Met78fs)" VariationType="Deletion" Accession="VCV000636274" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2019-07-22" MostRecentSubmission="2019-07-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="624086" VariationID="636274">
      <GeneList>
        <Gene Symbol="C19orf12" FullName="chromosome 19 open reading frame 12" GeneID="83636" HGNC_ID="HGNC:25443" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="29698886" stop="29715789" display_start="29698886" display_stop="29715789" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="30189792" stop="30206695" display_start="30189792" display_stop="30206695" Strand="-" />
          </Location>
          <OMIM>614297</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_031448.6(C19orf12):c.232_233del (p.Met78fs)</Name>
      <CanonicalSPDI>NC_000019.10:29702904:AT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="29702905" stop="29702906" display_start="29702905" display_stop="29702906" variantLength="2" positionVCF="29702904" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="30193812" stop="30193813" display_start="30193812" display_stop="30193813" variantLength="2" positionVCF="30193811" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>C19ORF12, 2-BP DEL, 265AT</Name>
      </OtherNameList>
      <ProteinChange>M89fs</ProteinChange>
      <ProteinChange>M14fs</ProteinChange>
      <ProteinChange>M78fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.29702905_29702906del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.29702905_29702906del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.30193812_30193813del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.30193812_30193813del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031970.2" sequenceAccession="NG_031970" sequenceVersion="2" change="g.17884_17885del">
            <Expression>NG_031970.2:g.17884_17885del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031726.4" sequenceAccession="NM_001031726" sequenceVersion="4" change="c.232_233del">
            <Expression>NM_001031726.4:c.232_233del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001026896.3" sequenceAccession="NP_001026896" sequenceVersion="3" change="p.Met78fs">
            <Expression>NP_001026896.3:p.Met78fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256046.3" sequenceAccession="NM_001256046" sequenceVersion="3" change="c.232_233del">
            <Expression>NM_001256046.3:c.232_233del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242975.1" sequenceAccession="NP_001242975" sequenceVersion="1" change="p.Met78fs">
            <Expression>NP_001242975.1:p.Met78fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256047.2" sequenceAccession="NM_001256047" sequenceVersion="2" change="c.232_233del">
            <Expression>NM_001256047.2:c.232_233del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242976.1" sequenceAccession="NP_001242976" sequenceVersion="1" change="p.Met78fs">
            <Expression>NP_001242976.1:p.Met78fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282929.1" sequenceAccession="NM_001282929" sequenceVersion="1" change="c.40_41del">
            <Expression>NM_001282929.1:c.40_41del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269858.1" sequenceAccession="NP_001269858" sequenceVersion="1" change="p.Met14fs">
            <Expression>NP_001269858.1:p.Met14fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282930.3" sequenceAccession="NM_001282930" sequenceVersion="3" change="c.40_41del">
            <Expression>NM_001282930.3:c.40_41del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269859.1" sequenceAccession="NP_001269859" sequenceVersion="1" change="p.Met14fs">
            <Expression>NP_001269859.1:p.Met14fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282931.3" sequenceAccession="NM_001282931" sequenceVersion="3" change="c.40_41del">
            <Expression>NM_001282931.3:c.40_41del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269860.1" sequenceAccession="NP_001269860" sequenceVersion="1" change="p.Met14fs">
            <Expression>NP_001269860.1:p.Met14fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031448.6" sequenceAccession="NM_031448" sequenceVersion="6" change="c.232_233del" MANESelect="true">
            <Expression>NM_031448.6:c.232_233del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_113636.2" sequenceAccession="NP_113636" sequenceVersion="2" change="p.Met78fs">
            <Expression>NP_113636.2:p.Met78fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="614297.0009" DB="OMIM" />
        <XRef Type="rs" ID="1599534276" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_031448.6(C19orf12):c.232_233del (p.Met78fs) AND Neurodegeneration with brain iron accumulation 4" Accession="RCV000788048" Version="1">
        <ClassifiedConditionList TraitSetID="7628">
          <ClassifiedCondition DB="MedGen" ID="C3280371">Neurodegeneration with brain iron accumulation 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-07-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-07-22" MostRecentSubmission="2019-07-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">29295770</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7628" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16586" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodegeneration with brain iron accumulation 4</ElementValue>
                <XRef ID="MONDO:0013674" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL PROTEIN-ASSOCIATED NEURODEGENERATION</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA4</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MPAN</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000512825" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553399" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508834" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520058" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552041" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529414" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12569" />
                <XRef ID="12569" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Mitochondrial membrane protein-associated neurodegeneration (MPAN) is characterized initially by gait changes followed by progressive spastic paresis, progressive dystonia (which may be limited to the hands and feet or more generalized), neuropsychiatric abnormalities (emotional lability, depression, anxiety, impulsivity, compulsions, hallucinations, perseveration, inattention, and hyperactivity), and cognitive decline. Additional early findings can include dysphagia, dysarthria, optic atrophy, axonal neuropathy, parkinsonism, and bowel/bladder incontinence. Survival is usually well into adulthood. End-stage disease is characterized by severe dementia, spasticity, dystonia, and parkinsonism.</Attribute>
                <XRef ID="NBK185329" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24575447</ID>
                <ID Source="BookShelf">NBK185329</ID>
              </Citation>
              <XRef ID="289560" DB="Orphanet" />
              <XRef ID="C3280371" DB="MedGen" />
              <XRef ID="MONDO:0013674" DB="MONDO" />
              <XRef Type="MIM" ID="614298" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1813398" SubmissionDate="2019-07-19" DateLastUpdated="2019-07-22" DateCreated="2019-07-22">
        <ClinVarSubmissionID localKey="614297.0009_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4, AUTOSOMAL DOMINANT" title="C19ORF12, 2-BP DEL, 265AT_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4, AUTOSOMAL DOMINANT" />
        <ClinVarAccession Accession="SCV000927066" DateUpdated="2019-07-22" DateCreated="2019-07-22" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a girl with neurodegeneration with brain iron accumulation-4 (NBIA4; 614298), born of nonconsanguineous Italian parents, Monfrini et al. (2018) detected a heterozygous de novo 2-bp deletion (c.265_266delAT, NM_001031726) in exon 3 of the C19ORF12 gene that resulted in frameshift and premature termination of the protein (Met89GlyfsTer12). Sanger sequencing of other genes mutant in neurodegeneration with brain iron accumulation did not detect other pathogenic mutations or rearrangements. Quantitative RT-PCR in lymphocytes showed that mRNA quantity in the proband was not reduced compared to that of the parents and controls, suggesting absence of degradation through nonsense-mediated decay. Sequence analysis of the C19ORF12 transcripts revealed presence of the mutation in the proband and ruled out aberrant splicing. Several other tissues (hair, saliva, and urine) in addition to lymphocytes were examined and no evidence of mosaicism was seen. Monfrini et al. (2018) hypothesized that the heterozygous variant is pathogenic and suggested that the mutation may have a dominant-negative effect, although they also noted the possibility that the patient has a mutation in an unidentified causative gene.</Attribute>
              <Citation>
                <ID Source="PubMed">29295770</ID>
              </Citation>
              <XRef DB="OMIM" ID="614298" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19ORF12" />
          </GeneList>
          <Name>C19ORF12, 2-BP DEL, 265AT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 265AT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614297.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4, AUTOSOMAL DOMINANT</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

